Twist Bioscience (TWST) Cash from Investing Activities (2017 - 2026)

Twist Bioscience has disclosed Cash from Investing Activities across 10 years of filings, most recently posting -$12.7 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 791.02% year-over-year to -$12.7 million; the TTM figure through Mar 2026 stood at -$44.4 million (down 796.31% YoY), while the FY2025 annual figure was -$24.8 million, down 706.32% from the prior year.
• Cash from Investing Activities declined to -$12.7 million in Q1 2026, from -$9.9 million in the prior quarter.
• Over the last five years, Cash from Investing Activities for TWST reached as high as $41.2 million in Q1 2023 and fell as low as -$13.3 million in Q1 2022.
• The 5-year median for Cash from Investing Activities is -$1.5 million (2024), against an average of -$365176.5.
• Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 409.61% — and 2025, when it tumbled 1221.66%.
• A 5-year view of Cash from Investing Activities shows it stood at -$7.0 million in 2022, then jumped by 159.75% to $4.2 million in 2023, then tumbled by 136.88% to -$1.5 million in 2024, then slumped by 546.68% to -$9.9 million in 2025, then retreated by 27.92% to -$12.7 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$12.7 million, -$9.9 million, and -$12.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.